Literature DB >> 15177039

The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX.

Ruiqiong Ye1, Aaron A Goodarzi, Ebba U Kurz, Shin'ichi Saito, Yuichiro Higashimoto, Martin F Lavin, Ettore Appella, Carl W Anderson, Susan P Lees-Miller.   

Abstract

The ataxia-telangiectasia mutated (ATM) protein kinase is activated in response to ionizing radiation (IR) and activates downstream DNA-damage signaling pathways. Although the role of ATM in the cellular response to ionizing radiation has been well characterized, its role in response to other DNA-damaging agents is less well defined. We previously showed that genistein, a naturally occurring isoflavonoid, induced increased ATM protein kinase activity, ATM-dependent phosphorylation of p53 on serine 15 and activation of the DNA-binding properties of p53. Here, we show that genistein also induces phosphorylation of p53 at serines 6, 9, 20, 46, and 392, and that genistein-induced accumulation and phosphorylation of p53 is reduced in two ATM-deficient human cell lines. Also, we show that genistein induces phosphorylation of ATM on serine 1981 and phosphorylation of histone H2AX on serine 139. The related bioflavonoids, daidzein and biochanin A, did not induce either phosphorylation of p53 or ATM at these sites. Like genistein, quercetin induced phosphorylation of ATM on serine 1981, and ATM-dependent phosphorylation of histone H2AX on serine 139; however, p53 accumulation and phosphorylation on serines 6, 9, 15, 20, 46, and 392 occurred in ATM-deficient cells, indicating that ATM is not required for quercetin-induced phosphorylation of p53. Our data suggest that genistein and quercetin induce different DNA-damage induced signaling pathways that, in the case of genistein, are highly ATM-dependent but, in the case of quercetin, may be ATM-dependent only for some downstream targets. Copyright 2003 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177039     DOI: 10.1016/j.dnarep.2003.10.014

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  15 in total

1.  Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer.

Authors:  Stuart A Rushworth; Olivier Micheau
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

2.  Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A.

Authors:  Aaron A Goodarzi; Jyoti C Jonnalagadda; Pauline Douglas; David Young; Ruiqiong Ye; Greg B G Moorhead; Susan P Lees-Miller; Kum Kum Khanna
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

3.  Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Sari Jäämaa; Henna M Moore; Juulia Enbäck; Pirjo Laakkonen; Anne Vaahtokari; Richard J Jones; Taija M af Hällström; Marikki Laiho
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

Review 4.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

5.  Phosphatidyl inositol 3-kinase-like serine/threonine protein kinases (PIKKs) are required for DNA damage-induced phosphorylation of the 32 kDa subunit of replication protein A at threonine 21.

Authors:  Wesley D Block; Yaping Yu; Susan P Lees-Miller
Journal:  Nucleic Acids Res       Date:  2004-02-10       Impact factor: 16.971

6.  Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine.

Authors:  Wesley D Block; Dennis Merkle; Katheryn Meek; Susan P Lees-Miller
Journal:  Nucleic Acids Res       Date:  2004-04-01       Impact factor: 16.971

7.  Tumor protein D52 represents a negative regulator of ATM protein levels.

Authors:  Yuyan Chen; Alvin Kamili; Jayne R Hardy; Guy E Groblewski; Kum Kum Khanna; Jennifer A Byrne
Journal:  Cell Cycle       Date:  2013-08-21       Impact factor: 4.534

8.  Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells.

Authors:  Praveen Rajendran; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Clin Epigenetics       Date:  2011-10-26       Impact factor: 6.551

9.  A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.

Authors:  Xudong Di; Danica M K Andrews; Charles J Tucker; Linda Yu; Alicia B Moore; Xiaolin Zheng; Lysandra Castro; Tonia Hermon; Hang Xiao; Darlene Dixon
Journal:  Exp Mol Med       Date:  2012-04-30       Impact factor: 8.718

Review 10.  Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression.

Authors:  J P Jose Merlin; H P Vasantha Rupasinghe; Graham Dellaire; Kieran Murphy
Journal:  Oxid Med Cell Longev       Date:  2021-06-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.